Skip to main content
AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)
Loading prices

US State Bill Tracker

Ohio Bills

Cannabis, kratom and 7-OH proposals, with recorded dates, pending status and past outcomes.

1 of 1 tracked bills

  • Kratom
    Did not pass; died when the session ended
    SB 103

    Regulate kratom and hemp-derived products

    Session: 135th General Assembly

    1. IntroducedDate TBC (done)
    2. PassedDid not happen (skipped)
    3. SignedDid not happen (skipped)
    4. Law in effectDid not happen (skipped)

    Action date not recorded

    Kratom / 7-OH bill, not a psychedelics bill. Proposed kratom-sales regulation; no enacted statewide framework identified.